US 12,290,415 B2
Method for delineating and linking/correlating opposing margins of a pathology specimen and immediately adjacent remaining in vivo margins
Shalom Strano, Jerusalem (IL); Alexander Lomes, Moshav Hosen (IL); and Steve Krupa, Haifa (IL)
Assigned to SPRINGLOC LTD., Jerusalem (IL)
Filed by SPRINGLOC LTD, Jerusalem (IL)
Filed on Dec. 30, 2022, as Appl. No. 18/091,912.
Application 18/091,912 is a continuation in part of application No. 18/083,565, filed on Dec. 18, 2022.
Application 18/091,912 is a continuation in part of application No. 17/841,663, filed on Jun. 16, 2022.
Application 18/091,912 is a continuation in part of application No. 17/724,487, filed on Apr. 19, 2022.
Application 17/841,663 is a continuation in part of application No. 17/724,487, filed on Apr. 19, 2022.
Claims priority of provisional application 63/296,465, filed on Jan. 4, 2022.
Claims priority of provisional application 63/293,643, filed on Dec. 23, 2021.
Claims priority of provisional application 63/231,243, filed on Aug. 10, 2021.
Claims priority of provisional application 63/218,973, filed on Jul. 7, 2021.
Claims priority of provisional application 63/179,893, filed on Apr. 26, 2021.
Prior Publication US 2023/0149119 A1, May 18, 2023
Int. Cl. A61B 90/00 (2016.01); A61B 5/06 (2006.01); A61B 10/00 (2006.01); A61B 90/98 (2016.01)
CPC A61B 90/39 (2016.02) [A61B 5/06 (2013.01); A61B 10/0041 (2013.01); A61B 90/98 (2016.02); A61B 2090/3908 (2016.02); A61B 2090/3954 (2016.02); A61B 2090/3966 (2016.02)] 23 Claims
OG exemplary drawing
 
1. A method for removing a body-of-tissue (BOT) from a patient, the method comprising:
i. excising the BOT thereby generating a cavity;
ii. fixing one or more in-vivo-markers (IVMs) to walls of the cavity;
iii. fixing one or more specimen markers (SpMs) to the BOT such that at least one location on the BOT that is associated with an SpM from the one or more SpMs is adjacent to a location in the cavity to which an IVM from the one or more IVMs was fixed thereby generating at least one set of IVM and SpM; and
iv. wherein at least one IVM from the one or more IVMs is associated with a unique identification (ID) that is configured to be visualized by an imaging system.